Story
Barclays Taps L’Oréal, Unilever as Top European Consumer Staples Picks
Summary
Barclays has named L’Oréal and Unilever its top picks in the European consumer staples sector, citing resilient demand for premium beauty and superior innovation as key advantages in a slowing market.
Barclays has identified L’Oréal and Unilever as its standout investment choices in the European consumer staples sector, according to a recent analyst note. The brokerage highlighted the companies' ability to navigate a more challenging market through strong innovation, effective brand investment, and exposure to resilient premium segments.
L’Oréal's Premium and China Edge
Barclays designated L’Oréal as its "clearest preferred name," citing the company's strong position in the high-end beauty market. Analysts believe the company is set to benefit from resilient premium beauty demand globally. The note also pointed to L’Oréal's continued strength in China, where its premium products are outperforming the broader, weaker market.
The firm's growth is expected to be further supported by accelerating global cosmetics demand. Barclays underscored that L’Oréal's differentiated products and strong digital execution are key factors that should continue to drive its performance.
AdUnilever's Innovation Strategy
Unilever was also highlighted as a top pick, with particular emphasis on its Beauty & Wellbeing division. According to Barclays, the broader consumer goods market is experiencing slowing category growth and rising promotional intensity, especially in Europe.
In this environment, companies that can successfully combine meaningful product innovation with more effective brand investment are best positioned to capture market share. Barclays views Unilever as one of the companies best equipped to execute this strategy, giving it a competitive advantage.
Read next
More on Stocks
CarMax Stock Surges on Strong Earnings Beat and Sales Rebound
CarMax reported fiscal second-quarter results that far exceeded analyst expectations, driven by a 13% jump in same-store sales and plans to resume its share buyback program.
Netflix Stock Gains After Deutsche Bank Upgrades to 'Buy'
Shares of the streaming giant rose after Deutsche Bank upgraded the stock to 'Buy' from 'Hold,' setting a $95 price target and citing a valuation opportunity following a prolonged selloff.
Amazon, GoodRx Prescription Subscriptions Gain Traction Amid Rising US Healthcare Costs
Amazon and GoodRx are seeing significant growth in their prescription drug subscription services as consumers seek alternatives to rising insurance premiums and out-of-pocket expenses.
SEC Proposes Scaling Back Sarbanes-Oxley Auditor Requirements
The U.S. Securities and Exchange Commission plans to reduce the number of companies required to have external auditors verify internal financial controls, a key post-Enron investor protection.